Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1003 of 1,261
  1. US 7713721

    Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted
  2. US 7713934

    Thrombin peptide derivatives

    The Board of Regents of the University of Texas System · Granted May 11, 2010 · Expires May 6, 2030

    granted
  3. US 7713983

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted May 11, 2010 · Expires May 6, 2030

    granted
  4. US 7713987

    Pyrimidine-2,4-diamines and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted
  5. US 7713995

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted
  6. US 7714014

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted
  7. US 7713529

    Methods for treating and preventing infectious disease

    The United States of America, as represented by the Department of Health and Human Services · Granted May 11, 2010 · Expires May 6, 2030

    granted
  8. US 7714007

    Method of alleviating chronic pain via peripheral glutaminase regulation

    The Board of Regents of the University of Oklahoma · Granted May 11, 2010 · Expires May 6, 2030

    granted
  9. US 7713925

    Syndecans and angiogenesis

    Regents of the University of Minnesota · Granted May 11, 2010 · Expires May 6, 2030

    granted
  10. US 7713927

    Antimicrobial peptides

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted
  11. US 7713931

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted
  12. US 7713526

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted
  13. US 7713710

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 11, 2010 · Expires May 6, 2030

    granted
  14. US 7713973

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 11, 2010 · Expires May 6, 2030

    granted
  15. US 7713939

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted
  16. US 7709625

    Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy

    The Board of Regents of the University of Texas · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  17. US 7709609

    Tumor suppressor gene, p47ING3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  18. US 7709190

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  19. US 7709482

    Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  20. US 7709643

    Synthesis of sodium narcistatin and related compounds

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  21. US 7709493

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  22. US 7709515

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Esperion Therapeutics, Inc. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  23. US 7709002

    Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  24. US 7709007

    Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted May 4, 2010 · Expires Apr 29, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.